The Foundation for Angelman Syndrome Therapeutics (FAST) and the Angelman Syndrome Foundation (ASF) formed a strategic partnership to drive a coordinated, multi-tiered advocacy strategy to improve the lives of those affected by Angelman syndrome.
Both organizations understand the need to ensure key decision makers understand Angelman syndrome to influence and inform policy, legislation, and funding related to AS.
We cannot accomplish our goals without YOU – caregivers, family, friends, research, and clinical partners. Please consider joining the AS Advocacy movement: Learn More
Sincerely,
Ryan Fischer (COO of FAST) & Amanda Moore (CEO of ASF)
Join us below at these dedicated Angelman syndrome events to support the advocacy efforts towards an approved therapeutic.
Virtual
Be sure to complete the survey and register to attend virtually.
Virtual
Washington, DC
SAVE THE DATE: Plan to arrive by early afternoon on Tuesday, March 4th for training and leave the evening of March 5th after your meetings. ...
Washington, DC
If you are interested in getting involved or have a question, please email us today.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.